keyword
MENU ▼
Read by QxMD icon Read
search

Enbrel, antibody therapy, cell therapy

keyword
https://www.readbyqxmd.com/read/21497255/-alopecia-areata-during-anti-tnf-alpha-therapy-nine-cases
#1
E Le Bidre, G Chaby, L Martin, M Perrussel, B Sassolas, M-L Sigal, C Kaassis, E Lespessailles, A Nseir, E Estève
BACKGROUND: In recent years, a growing number of biological agents have been introduced for the treatment of various diseases, and their principal adverse events are known. We present nine cases of alopecia areata (AA) developed in patients treated with TNF-α blocking agents. PATIENTS AND METHODS: Nine cases are described: five men and four women of mean age 39.2 years (range: 29-54 years). Two patients had a past history of alopecia areata. The anti-TNF given was adalimumab (Humira(®)) in eight cases and etanercept (Enbrel(®)) in one case...
2011: Annales de Dermatologie et de Vénéréologie
https://www.readbyqxmd.com/read/16738958/hereditary-auto-inflammatory-disorders-and-biologics
#2
REVIEW
Leigh D Church, Sarah M Churchman, Philip N Hawkins, Michael F McDermott
The term auto-inflammatory disorders has been coined to describe a group of conditions characterized by spontaneously relapsing and remitting bouts of systemic inflammation without apparent involvement of antigen-specific T cells or significant production of auto-antibodies. The hereditary periodic fever syndromes are considered as the prototypic auto-inflammatory diseases, and genetic studies have yielded important new insights into innate immunity. DNA analysis has greatly enhanced the clinical characterization of these conditions, and elucidation of their molecular aetiopathogenesis has suggested that therapies may be aimed at specific targets within the immune cascade...
June 2006: Springer Seminars in Immunopathology
https://www.readbyqxmd.com/read/15846506/silencing-tnfalpha-activity-by-using-remicade-or-enbrel-blocks-inflammation-in-whole-muscle-grafts-an-in-vivo-bioassay-to-assess-the-efficacy-of-anti-cytokine-drugs-in-mice
#3
Miranda D Grounds, Marilyn Davies, Jo Torrisi, Thea Shavlakadze, Jason White, Stuart Hodgetts
Dramatic clinical success in the treatment of chronic inflammatory diseases has resulted from the use of anti-cytokine therapies including specific blocking antibodies, soluble receptors and traps to silence the actions of inflammatory cytokines such as tumour necrosis factor alpha (TNFalpha) and interleukin-1 (IL-1). Two agents used clinically to block the functional activity of TNFalpha protein are Remicade (an antibody) and Enbrel (a soluble TNF receptor). These tools are now being extended to many other clinical disorders...
June 2005: Cell and Tissue Research
https://www.readbyqxmd.com/read/15080292/new-biologic-therapies-for-psoriatic-disease
#4
Kimberly A Bohjanen, Steven E Prawer
Psoriasis is a common cutaneous disease that can have a profound effect on an individual's life. New biologic drugs--proteins that are synthesized using recombinant DNA technology to mimic naturally occurring molecules and that selectively target the immune system--have changed the paradigm for treating this disease. We review 4 biologic drugs that are either currently FDA approved or in phase 3 studies: Alefacept (Amevive) and efalizumab (Raptiva), which are T-cell modulators; etanercept (Enbrel), a soluble TNF receptor; and infliximab (Remicade), an anti-TNF monoclonal antibody...
March 2004: Minnesota Medicine
https://www.readbyqxmd.com/read/15075543/a-study-of-the-safety-immunology-virology-and-microbiology-of-adjunctive-etanercept-in-hiv-1-associated-tuberculosis
#5
COMPARATIVE STUDY
Robert S Wallis, Peter Kyambadde, John L Johnson, Libby Horter, Rodney Kittle, Monika Pohle, Constance Ducar, Monica Millard, Harriet Mayanja-Kizza, Christopher Whalen, Alphonse Okwera
OBJECTIVE: Tumor necrosis factor (TNF), an important inflammatory mediator in tuberculosis, has been implicated in causing accelerated HIV disease progression in HIV-associated tuberculosis. However, TNF blockade, particularly by monoclonal antibody, has been associated with the reactivation of latent Mycobacterium tuberculosis infection by the impairment of mycobacterial immunity. This phase 1 study examined the safety, microbiology, immunology, and virology of TNF blockade using etanercept (soluble TNF receptor, Enbrel) during the initial treatment of HIV-associated tuberculosis...
January 23, 2004: AIDS
https://www.readbyqxmd.com/read/11583065/etanercept-in-rheumatoid-arthritis
#6
REVIEW
A Alldred
Etanercept (Enbrel, Immunex Corporation, Seattle, Washington, USA) is a new biological disease-modifying antirheumatic drug (DMARD) for the treatment of active rheumatoid arthritis (RA). It is one of two TNF-alpha blockers to be licensed for the treatment of active RA and is classified as a recombinant human soluble TNF receptor. The drug competitively inhibits the binding of TNF to cell surface receptors and thus renders TNF biologically inactive. In doing so, etanercept inhibits the pro-inflammatory effects of TNF and results in a reduction of joint inflammation in patients with RA...
July 2001: Expert Opinion on Pharmacotherapy
https://www.readbyqxmd.com/read/11583062/new-developments-in-the-prophylaxis-and-treatment-of-graft-versus-host-disease
#7
REVIEW
D Simpson
Graft versus host disease (GVHD) remains the major obstacle to successful allogeneic bone marrow transplantation. Cyclosporin with methotrexate is the most common prophylactic regimen. Tacrolimus is associated with less GVHD and is gaining ground especially in unrelated donor transplants where current regimens are unsatisfactory. Mycophenolate mofetil (MMF) and rapamycin have not yet shown benefit in acute GVHD prophylaxis. In vivo T-cell depletion with Campath 1H or thymoglobulin used during transplant conditioning are increasingly used in place of ex vivo T-cell depletion, where results remain disappointing...
July 2001: Expert Opinion on Pharmacotherapy
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"